Therefore, current study aimed to evaluate captopril and BTxA as anti-cancer agents in relation to their p53 pro-apoptotic potential in cancer cells as the success of restoring the activity of p53 reported to be a miracle weapon against cancer (27). The gene discussed is TP53; the disease is cancer.